NCT05775614

Brief Summary

The purpose of the current study is to investigate whether catheter flushing with Uro-Tainer® with citric acid and Uro-Tainer® Polihexanide can: Reduce catheter changes due to incrustation and blockage. In addition, a list of secondary aims inclusive of cost-effectiveness analysis in collaboration with the Centre for Innovative Medical Technology (CIMT) at OUH.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
20mo left

Started May 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
May 2022Jan 2028

Study Start

First participant enrolled

May 1, 2022

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

December 17, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 20, 2023

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2028

Last Updated

September 18, 2025

Status Verified

September 1, 2025

Enrollment Period

4.7 years

First QC Date

December 17, 2022

Last Update Submit

September 14, 2025

Conditions

Keywords

Catheter maintenanceUroTainerprophylacticcatheter flushing

Outcome Measures

Primary Outcomes (1)

  • Number of catheter changes during the treatment and follow-up period.

    Number of catheter changes

    1 year

Secondary Outcomes (8)

  • UTI events (Urinary tract infection event)

    1 year

  • Urine culture

    1 year

  • Odour

    1 year

  • Quality of life by SF-36

    1 year

  • Quality of life by ICIQ-LTCqol

    1 year

  • +3 more secondary outcomes

Study Arms (2)

Uro-Tainer® catheter flushing

EXPERIMENTAL

Uro-Tainer® catheter flushing two times weekly for 3 months.

Device: UroTainer®

Saline catheter flushing

PLACEBO COMPARATOR

Saline solution catheter flushing two times weekly for 3 months.

Device: Saline

Interventions

Clinical effect of preventive treatment - catheter flushing with UroTainer®

Uro-Tainer® catheter flushing
SalineDEVICE

Clinical effect of preventive treatment - catheter flushing with saline solution

Saline catheter flushing

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Citizen not previously flushed
  • A permanent catheter (suprapubic and urethral)
  • Male and female \> 18 years of age
  • Acute or previous catheter stop because of blocking or incrustations.
  • The pilot project does not include clogging due to incrustations
  • Voluntary consent to participate in the study, following a full explanation of the nature and purpose of the study, by signing the informed consent form approved by the Ethics Committee (EC) before all evaluations.
  • Citizen previously flushed with NaCl or UroTainer®
  • A permanent catheter (suprapubic and urethral)
  • Male and female \> 18 years of age
  • Willingness to take a rinse break for a minimum of 4 weeks. In the event of 2 catheter stops during the flushing break, assessed on the basis of an urgent need for catheter flushing with NaCl or catheter change, the citizen can be included.
  • The pilot project does not include clogging due to incrustations
  • If there is no catheter stop during the rinsing break, the citizen will continue without rinsing until a possible catheter stop.
  • Voluntary consent to participate in the study, following a full explanation of the nature and purpose of the study, by signing the informed consent form approved by the Ethics Committee (EC) before all evaluations.

You may not qualify if:

  • Urothelial cancer
  • Bladder and kidney stones requiring treatment
  • Age \< 18 years of age
  • Pregnant and / or breastfeeding women
  • Not able to understand Danish
  • Dementia, where relatives can / will not give consent
  • Simultaneous participation in another interventional clinical trial (drugs or medical devices studies)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Odense University Hospital

Odense, 5000, Denmark

Location

Study Officials

  • Karin Andersen

    University of Southern Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: 2 arms with randomization 1:1 1. Uro-Tainer® Polihexanide two weekly rinses compared to two weekly rinses with saline for 3 months. 2. Uro-Tainer® with citric acid: Two weekly rinses compared to two weekly rinses with saline for 3 months.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 17, 2022

First Posted

March 20, 2023

Study Start

May 1, 2022

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2028

Last Updated

September 18, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations